EP-1778: On the feasibility of performing a 3D-scan with your own smartphone  by Pérez-Alija, J. et al.
ESTRO 35 2016                                                                                                                                                    S833 
________________________________________________________________________________ 
 
 
The largest magnitude of Σ and σ for H&N was 1.94 mm, SNC 
was 1.56 mm, breast was 1.87 mm, thorax was 3.33 mm, 
pelvis was 3.75 mm and prostate was 2.89 mm. The PTV 
margins required are <4.5 mm for brain and H&N lesions, 
<5.5 mm for breast cancers, but range from 4.5 to 9 mm for 
thorax, prostate and pelvis lesions. 
Theses values indicate the setup variations of each patient. 
The variations were smaller for the breast, SNC and H&N 
cohorts than the prostate, pelvis and thorax cohorts. The 
pelvis and breast cohorts showed the greatest variation in 
lateral direction and the prostate cohorts in vertical 
direction. The largest variation were presented in thorax 
cohorts in longitudinal direction and the lowest were in the 
SNC cohorts. 
 
Conclusion: As the setup errors vary according to each 
immobilization systems, the analysis of each institution`s 
specific setup errors is essential for determining the PTV 
margins. The results were also used to define action level for 
online correction. 
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Purpose or Objective: The purpose of this project is to 
gather knowledge on the movement of pelvic lymph nodes 
relative to the prostate, seminal vesicles and bones in the 
pelvis and how this may affect the patient treatment plan.  
 
Material and Methods: Until present, 10 patients have been 
included in the study. All patients have diagnosed prostate 
cancer and were treated with radiation therapy with curative 
intent. The patients followed the normal preparation and 
treatment procedure at our clinic - however, six additional 
MRI scans were acquired (baseline: before RT, on treatment 
day 1, 3, 5, 20 and 35) see figure. In each image set, several 
structures were delineated including fiducial markers, bony 
structures and lymph nodes. A radiologist identified lymph 
nodes along the common spread paths of prostate cancer. No 
suspected pathological nodes were found. Oncentra (Elekta) 
was used for image registration. Baseline images were 
defined as reference images and all other examinations were 
registered to the reference in two separate ways; bone 
matching and fiducial markers matching. For the bone 
matching, four structures were outlined; the disc between 
S1-S2, head of the right and left femur and the pubic 
symphysis. For the fiducial marker matching, the three gold 
markers in the prostate were outlined. In both cases the 
images were manually matched. Lymph node, seminal vesicle 
and prostate movements and morphological change were 
evaluated In MATLAB. Lymph nodes were grouped into 
regions: para-aortic (PA), common iliac (CI), pre-sacral (PS), 
internal iliac (II), obturator (Obt), and external iliac (EI) 
lymph nodes. 
 
 
 
Results: We found that prostate moves up to 10 mm in 
anterior-posterior direction and up to 5 mm in right-left and 
cranio-caudal directions relative to bony anatomy from 
baseline scan. The lymph node group with the largest 
movements in right-left direction were CI with up to 20 mm 
difference from baseline. In the anterior-posterior and 
cranio-caudal directions, the maximum movement was 9 mm 
relative to bone from baseline scan. For the lymph nodes in 
the EI and PS regions, a significant difference was found 
depending on whether bone or fiducial markers were used for 
registration in right-left or cranio-caudal directions. In the 
other cases, no statistically significant difference between 
bone matching and fiducial marker matching was found 
 
Conclusion: Preliminary findings suggest that the pelvic 
lymph nodes are more mobile than expected, indicating the 
need to account for that in treatment planning. However, 
more patients need to be included in the study before a 
conclusion can be drawn on the implications on the 
treatment plan. 
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Purpose or Objective: Optical 3D Surface Scanner (3D-OSS) is 
a simple and easily reproducible method for patient 
alignment, and is an accurate tool to show anatomical 
changes, for example, in breast locations. The aim of this 
study was to evaluate the feasibility of both achieving within 
a few minutes an 3D-OSS using a smartphone and creating an 
image fusion between this 3D-OSS and the CT scanner, in a 
simple, cheap and reliable way. 
 
Material and Methods: A smartphone and a free commercial 
app (TRNIO, www.trnio.com) were used to create an 3D-OSS. 
This app takes a series of pictures of your object as you move 
your smartphone around it. After a scan is completed, a 3D 
model will be generated on your phone. This 3D map is 
available for downloading on the TRNIO website. Although 
there are several image reconstructing algorithms available, 
in order to first show the feasibility of the method described 
here we will be using the commercial app. In the meantime, 
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we are now ourselves developing an In-house software to do 
this. The RANDO Man Phantom (The Phantom Laboratories, 
Salem, New York) was used as a model. RANDO represents a 
175cm tall and 73.5kg male figure. The phantom is 
constructed with a natural human skeleton which is cast 
inside soft tissue-simulating material. An image fusion was 
carried out between a RANDO OSS and a RANDO CT scan. A 
Body structure was created in our CT scan. In order to fusion 
it with the 3D-OSS we used MeshLab (a free processing 
system for 3D triangular meshes). 
 
Results: Image fusion was successfully performed and the 
accuracy of it was measured both using predefined 
corresponding landmarks in the CT and visual confirmation. 
We performed this process for two locations on the phantom, 
Head & Neck and Body, and in both cases we got an accurate 
agreement. 
 
 
 
Conclusion: This study was carried out using an existing 
commercial app in order to prove the feasibility of the 
method, using only a smartphone and free software. 
Therefore, we think it reasonable to believe that making your 
own 3D-OSS system could be done both in a simple and in a 
much cheaper way than the usually commercial alternatives 
available on the market. 
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Purpose or Objective: In external beam radiotherapy for 
prostate cancer, image-guidance using fiducial-markers 
decrease set-up error and inter-fractional organ-motion 
error. However, daily deformity and/or rotation of the 
prostate/seminal vesicle could not be adequately detected 
by the verification of fiducial-marker position alone. The 
purpose of this study was to know how many margins should 
be added to compensate for the daily deformity and/or 
rotation of the prostate/seminal vesicle in the image-guided 
radiotherapy using fiducial-markers. 
 
Material and Methods: Three-hundred ten fractions of nine 
patients with prostate cancer were examined. Patient setup 
was performed according to the position of two intra-
prostate fiducial-markers (first-stage). Thereafter, with 
considering deformity and/or rotation of the 
prostate/seminal vesicle, the patient position was moved to 
the best position to achieve an alignment of contours of the 
prostate/seminal vesicle on daily cone-beam CT and contours 
of the clinical target volumes delineated on treatment 
planning CT (second-stage). Distance of movement in the 
second-stage was measured. 
 
Results: An alignment in the second-stage was needed in 47 
fractions of 310 fractions (15.2%). In 43 fractions (13.9%), 
movement of 1 mm was needed only in antero-posterior (AP) 
direction. Movement of 2 mm in AP direction, movement of 1 
mm in cranio-caudal (CC) direction, and movement of 1 mm 
in AP and CC directions were needed in two fractions (0.6%), 
in one fraction (0.3%), and in one fraction (0.3%), 
respectively. No fraction needed an alignment in left-right 
direction. 
 
Conclusion: With regard to image-guided external beam 
radiotherapy based on intra-prostate fiducial-marker 
position, margins of 1-2 mm in AP direction are necessary to 
compensate for the daily deformity and/or rotation of the 
prostate/seminal vesicle. 
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Purpose or Objective: Linac radiation isocenter describes a 
path while gantry and couch are rotating during the 
treatment delivery of typical non-coplanar SRS plans. The 
aim of this study is to investigate the dosimetric impact of 
this isocenter "wobble" in SRS of a vestibular schwannoma 
(VS), and to validate the PTV margin used in our clinical 
practice. 
 
Material and Methods: Five VS cases were enrolled in this 
study. The PTV was generated in the Eclipse TPS by 
expanding the CTV by an isotropic 2 mm margin, according to 
our SRS policy. A SRS non-coplanar plan ("reference plan") 
was designed in the Eclipse TPS by using static gantry IMRT 
technique. Eleven beams (6 MV) from a Varian Clinac 
equipped with a 120 Millennium MLC were used. Dose of 12.5 
Gy (100%) was prescribed to cover 99 % of PTV.  
On the other hand, fifteen CBCT-guided end-to-end (E2E) 
tests using a skull phantom were performed. E2E test permits 
to quantify the radiation isocenter misalignments in the X 
(lateral), Y (anterior-posterior) and Z (superior-inferior) 
directions.  
For each VS case, eight X-Y-Z shifts generated from "mean ± 
1.96 x SD" misalignments reported by E2E tests were 
simulated in the Eclipse TPS, resulting in eight "shifted 
plans". The following metrics were computed for each shifted 
plan and compared to the reference plan values: i) dose 
coverage of the CTV (D99%_CTV), ii) maximum dose to 
brainstem, iii) mean doses to cochlea, and iv) V10Gy, V5Gy 
and V2.5Gy of the brain (including the PTV). 
 
Results: 1) Isocenter misalignments revealed by E2E tests 
were (mean ± SD): -0.4 ± 0.7 mm, -0.2 ± 0.5 mm and 0.2 ± 
0.4 mm, in the X, Y and Z directions, respectively. Gaussian 
behavior was observed for each direction (p> 0.05; Shapiro-
Wilk test). The probability of having shifts ≥ 2 mm is less than 
1% in Lat, AP, and SI directions.  
2) Target coverage was assured in the shifted plans; 
D99%_CTV: 103.1% ± 5.8% .  
3) Shifted plans vs. reference ones revealed not statistically 
differences (p> 0.05; Two-tailed Student t-test) in brainstem 
maximum dose (7.1 ± 3.0 Gy vs. 7.2 ± 3.1 Gy) ; cochlear 
mean dose (5.3 ± 4.1 Gy vs. 5.1 ± 4.4 Gy) ; V10Gy brain (2.3 ± 
1.5 cm3 vs. 2.3 ± 1.6 cm3); V5Gy brain (8.6 ± 5.1 cm3 vs. 8.6 
± 5.8 cm3); and V2.5Gy brain (43.4 ± 26.7 cm3 vs. 43.5 ± 30.1 
cm3). 
 
Conclusion: 
1) The radiation isocenter "wobble" did not increase 
significantly the doses to brainstem, cochlea and brain.  
2) Our study demonstrated that the 2 mm PTV margin used in 
our clinical practice was adequate for SRS treatment of VS.  
 
 
